LEUVAS THERAPEUTICS has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BEIJING YUEHAO TECH DEVELOPMENT CO LTD, INST PATHOGEN BIOLOGY CAMS and THE SEC DEP FOR HEALTH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Peptides | |
#7 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Constantin Gabriela | 8 |
#2 | De Franceschi Lucia | 3 |
#3 | Laudanna Carlo | 3 |
Publication | Filing date | Title |
---|---|---|
EP3454943A1 | Blockade of tim-1 pathways and p-selectin pathways in treatment of neuroinflammatory degenerative disease | |
US2018256687A1 | Modulators of protein tyrosine phosphatase and uses thereof | |
EP3052189A1 | Modulation of leukocyte activity in treatment of neuroinflammatory degenerative disease |